Insights

Precision Immune Monitoring Immudex specializes in antigen-specific immune cell detection through Dextramer technology, presenting a compelling value proposition for researchers needing high-sensitivity immune profiling in T cells, non-conventional T cells, B cells, and CAR cells.

Workflow Integration Their product portfolio supports flow cytometry, next-generation sequencing, and single-cell multi-omics, suggesting opportunities to position Immudex as a complementary solution across existing workflows in leading biotech and pharma laboratories.

Lab-Ready Customization Recent product launches such as U-Load Dextramer enable researchers to assemble custom antigen-specific reagents in-house, indicating demand for flexible, rapid-turnaround reagent sets and potential upsell of add-ons or support services.

Strategic Partnerships Historical collaboration with BD and STEMCELL Technologies signals openness to co-development and integration opportunities; pursue partnerships around combined workflows, validated assays, and co-marketed solutions.

Growth Potential With a smaller company footprint and a revenue range in the low single-digit millions, there is scale-up potential through expanded customer segments (academic, biotech, CROs) and expanded international reach aligned with peers that have higher revenue and headcount.

Immudex Tech Stack

Immudex uses 8 technology products and services including Hotjar, Cart Functionality, Pikaday, and more. Explore Immudex's tech stack below.

  • Hotjar
    Analytics
  • Cart Functionality
    E-commerce
  • Pikaday
    Javascript Libraries
  • OWL Carousel
    Javascript Libraries
  • pdfmake
    Javascript Libraries
  • reCAPTCHA
    Security
  • Microsoft IIS
    Web Servers
  • CSS
    Web Tools And Plugins

Media & News

Immudex's Email Address Formats

Immudex uses at least 1 format(s):
Immudex Email FormatsExamplePercentage
FL@immudex.comJD@immudex.com
74%
LF@immudex.comDJ@immudex.com
16%
First_Last@immudex.comJohn_Doe@immudex.com
5%
Last@immudex.comDoe@immudex.com
5%

Frequently Asked Questions

What is Immudex's phone number?

Minus sign iconPlus sign icon
You can contact Immudex's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Immudex's official website and social media links?

Minus sign iconPlus sign icon
Immudex's official website is immudex.com and has social profiles on LinkedIn.

What is Immudex's SIC code NAICS code?

Minus sign iconPlus sign icon
Immudex's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Immudex have currently?

Minus sign iconPlus sign icon
As of July 2026, Immudex has approximately 48 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: P. D.Chief Scientific Officer: L. B.Chief Operating Officer: P. I.. Explore Immudex's employee directory with LeadIQ.

What industry does Immudex belong to?

Minus sign iconPlus sign icon
Immudex operates in the Biotechnology Research industry.

What technology does Immudex use?

Minus sign iconPlus sign icon
Immudex's tech stack includes HotjarCart FunctionalityPikadayOWL CarouselpdfmakereCAPTCHAMicrosoft IISCSS.

What is Immudex's email format?

Minus sign iconPlus sign icon
Immudex's email format typically follows the pattern of FL@immudex.com. Find more Immudex email formats with LeadIQ.

When was Immudex founded?

Minus sign iconPlus sign icon
Immudex was founded in 2009.
Immudex logo

Immudex

Biotechnology ResearchHovedstaden, Denmark11-50 Employees

Immudex is a life science company based in Copenhagen, Hovedstaden. Its Dextramer technology supports precision immune monitoring by enabling detection of antigen-specific immune cells and allowing the study of diverse immune cell types, including T cells, non-conventional T cells, B cells, and CAR cells.

Its customers are researchers in biotechnology and life sciences seeking tools to profile immune responses. In the biotechnology research field, the company provides reagents and methods to support immune profiling. In November 2025, Immudex and STEMCELL Technologies announced a protocol for rapid and gentle enrichment of antigen-specific T cells.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2009
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Immudex's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Immudex's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.